The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Clinical trial NCT03951623 · COMPLETED

Trial details

NCT number: NCT03951623
Sponsor: Hutchison Medipharma Limited
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Immune Thrombocytopenia (ITP)

Start date: 2019-08-12
Primary completion: 2021-10-30
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.